Compound heterozygosity involving Antithrombin Cambridge II (p.Ala416Ser) in antithrombin deficiencyAGUILA, Sonia; MARTINEZ-MARTINEZ, Irene; VICENTE, Vicente et al.Thrombosis and haemostasis. 2013, Vol 109, Num 3, pp 556-558, issn 0340-6245, 3 p.Article

ABO blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphismsMINANO, Antonia; ORDONEZ, Adriana; VICENTE, Vicente et al.Haematologica (Roma). 2008, Vol 93, Num 5, pp 729-734, issn 0390-6078, 6 p.Article

Report of three cases of circulating heparin-like anticoagulantsLLAMAS, Pilar; OUTEIRINO, Julio; ESPINOZA, José et al.American journal of hematology. 2001, Vol 67, Num 4, pp 256-258, issn 0361-8609Article

Immunophenotype in chronic myelomonocytic leukemia : is it closer to myelodysplastic syndromes or to myeloproliferative disorders?SUBIRA, Dolores; FONT, Patricia; LLAMAS, Pilar et al.Translational research. 2008, Vol 151, Num 5, pp 240-245, 6 p.Article

Legg-perthes disease and heritable thrombophiliaLOPEZ-FRANCO, Mariano; GONZALEZ-MORAN, Gaspar; DE LUCAS, José Carlos et al.Journal of pediatric orthopedics. 2005, Vol 25, Num 4, pp 456-459, issn 0271-6798, 4 p.Article

High Molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon a 2bFERNANDEZ-RUIZ, Elena; CABRERIZO, Maria; FERNANDEZ-RANADA, José Maria et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2497-2503, issn 1078-0432, 7 p.Article